Clinical Trial Update: Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma [NA]

View source ↗

Summary

The clinical trial NCT01455363 evaluating post-occlusive reactive hyperemia in basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Snippet

Sponsor: Institut Curie | Conditions: Carcinoma, Basal Cell | NA | Status: COMPLETED